University of Chicago Medical Center ( Site 5037) — Chicago, Illinois

Public research footprint of University of Chicago Medical Center ( Site 5037), compiled from the ClinicalTrials.gov public registry.

848

Registered studies

287

Active

161

Recruiting now

377

Completed

165

Stopped or withdrawn

Most-studied conditions

PDAC · Pancreatic Cancer Metastatic · Squamous Cell Carcinoma of Head and Neck · Resectable Non-Small-Cell Lung Cancer

Recently updated registry entries

NCT06822426 — Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream… (Recruiting)
NCT07071519 — A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative… (Recruiting)
NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Chicago Medical Center ( Site 5037)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.